CTI BioPharma Corp. Company Profile (NASDAQ:CTIC)

About CTI BioPharma Corp.

CTI BioPharma Corp. logoCTI BioPharma Corp. (CTI) is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers to patients and healthcare providers. The Company is primarily focused on commercializing PIXUVRI in select countries in the European Union, for multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (NHL). It is also engaged in evaluating pacritinib for the treatment of adult patients with myelofibrosis. Its earlier stage product candidate, tosedostat, is an oral, once-daily aminopeptidase inhibitor that has demonstrated responses in patients with acute myeloid leukemia (AML). It also evaluates its pipeline candidate paclitaxel poliglumex (Opaxio), which targets solid tumors. It is evaluating Opaxio through cooperative group sponsored trials and investigator-sponsored trials (ISTs), such as the ongoing maintenance therapy trial in patients with ovarian cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CTIC
  • CUSIP:
Key Metrics:
  • Previous Close: $0.40
  • 50 Day Moving Average: $0.354
  • 200 Day Moving Average: $0.452
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.61
  • P/E Growth: 0.000
  • Market Cap: $112.40M
  • Outstanding Shares: 279,604,000
  • Beta: 1.18
Additional Links:
Companies Related to CTI BioPharma Corp.:

Analyst Ratings

Consensus Ratings for CTI BioPharma Corp. (NASDAQ:CTIC) (?)
Ratings Breakdown: 1 Sell Rating, 2 Hold Ratings
Consensus Rating:Hold (Score: 1.67)
Consensus Price Target: $0.91 (127.20% upside)

Analysts' Ratings History for CTI BioPharma Corp. (NASDAQ:CTIC)
Show:
DateFirmActionRatingPrice TargetDetails
8/29/2016Piper Jaffray Cos.Reiterated RatingNeutralView Rating Details
2/10/2016Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details
2/10/2016WallachBeth CapitalDowngradeHold -> SellView Rating Details
2/8/2016S&P Equity ResearchLower Price Target$0.48 -> $0.39View Rating Details
8/14/2015Roth CapitalReiterated RatingBuy$4.50View Rating Details
6/1/2015Janney Montgomery ScottReiterated RatingBuy -> Fair Value$3.50 -> $1.94View Rating Details
5/10/2015HC WainwrightReiterated RatingBuy$6.00 -> $4.00View Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for CTI BioPharma Corp. (NASDAQ:CTIC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q2($0.10)($0.07)ViewN/AView Earnings Details
5/10/2016Q1($0.04)$0.01ViewN/AView Earnings Details
2/16/2016Q4($0.18)($0.13)ViewN/AView Earnings Details
11/5/2015Q315($0.12)($0.19)$18.89 million$1.00 millionViewListenView Earnings Details
8/6/2015Q215($0.10)($0.19)$12.77 million$1.10 millionViewListenView Earnings Details
5/6/2015Q115($0.14)($0.16)$9.84 million$2.73 millionViewListenView Earnings Details
3/12/2015Q414($0.18)($0.27)$2.48 million$17.80 millionViewListenView Earnings Details
10/29/2014Q3$0.03$0.03ViewListenView Earnings Details
8/4/2014Q2($0.12)($0.19)ViewListenView Earnings Details
4/29/2014Q114($0.17)($0.20)$1.10 million$1.40 millionViewN/AView Earnings Details
3/4/2014Q4($0.16)$0.08$1.26 million$32.90 millionViewListenView Earnings Details
2/28/2013Q4 2012($0.20)($0.20)$1.00 millionViewListenView Earnings Details
11/1/2012Q312($0.38)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for CTI BioPharma Corp. (NASDAQ:CTIC)
Current Year EPS Consensus Estimate: $-0.23 EPS
Next Year EPS Consensus Estimate: $-0.25 EPS

Dividends

Dividend History for CTI BioPharma Corp. (NASDAQ:CTIC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for CTI BioPharma Corp. (NASDAQ:CTIC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/24/2016James A BiancoCEOSell10,000$0.37$3,700.00View SEC Filing  
5/27/2016James A BiancoCEOSell10,000$0.45$4,500.00View SEC Filing  
4/29/2016James A BiancoCEOSell10,000$0.52$5,200.00View SEC Filing  
3/28/2016James A BiancoCEOSell10,000$0.49$4,900.00View SEC Filing  
3/21/2016James A BiancoCEOSell318,169$0.55$174,992.95View SEC Filing  
3/4/2016Matthew PlunkettEVPSell10,000$0.59$5,900.00View SEC Filing  
2/26/2016Jack W SingerEVPSell15,000$0.63$9,450.00View SEC Filing  
2/26/2016James A BiancoCEOSell10,000$0.63$6,300.00View SEC Filing  
2/16/2016James A BiancoCEOSell100,000$0.42$42,000.00View SEC Filing  
2/4/2016Matthew PlunkettEVPSell10,000$1.15$11,500.00View SEC Filing  
1/29/2016Jack W. SingerEVPSell15,000$1.18$17,700.00View SEC Filing  
1/29/2016James A BiancoCEOSell10,000$1.20$12,000.00View SEC Filing  
1/8/2016Value Fund L P BiotechnologyInsiderBuy1,001,327$1.22$1,221,618.94View SEC Filing  
1/4/2016Matthew PlunkettEVPSell10,000$1.21$12,100.00View SEC Filing  
12/30/2015James A. BiancoCEOSell110,000$1.26$138,600.00View SEC Filing  
12/28/2015James A. BiancoCEOSell10,000$1.29$12,900.00View SEC Filing  
12/18/2015Jack W. SingerEVPSell15,000$1.18$17,700.00View SEC Filing  
12/4/2015Matthew PlunkettEVPSell10,000$1.00$10,000.00View SEC Filing  
11/27/2015Jack W. SingerEVPSell15,000$1.21$18,150.00View SEC Filing  
11/27/2015James A BiancoCEOSell10,000$1.23$12,300.00View SEC Filing  
11/19/2015Louis A. BiancoEVPSell15,000$1.13$16,950.00View SEC Filing  
10/30/2015James A BiancoCEOSell260,000$1.35$351,000.00View SEC Filing  
10/29/2015Louis A. BiancoEVPSell10,000$1.41$14,100.00View SEC Filing  
10/23/2015Jack W. SingerEVPSell15,000$1.62$24,300.00View SEC Filing  
10/22/2015Louis A BiancoEVPSell10,000$1.58$15,800.00View SEC Filing  
10/5/2015Matthew PlunkettEVPSell10,000$1.52$15,200.00View SEC Filing  
9/30/2015Jack W. SingerEVPSell100,000$1.42$142,000.00View SEC Filing  
9/30/2015James A. BiancoCEOSell600,000$1.43$858,000.00View SEC Filing  
9/30/2015Richard L. LoveDirectorSell13,660$1.45$19,807.00View SEC Filing  
9/29/2015Louis A. BiancoEVPSell170,000$1.41$239,700.00View SEC Filing  
9/25/2015Jack W. SingerEVPSell15,000$1.64$24,600.00View SEC Filing  
9/24/2015Matthew PlunkettEVPSell75,869$1.57$119,114.33View SEC Filing  
9/4/2015Matthew PlunkettEVPSell10,000$1.54$15,400.00View SEC Filing  
8/28/2015Jack W. SingerEVPSell15,000$1.58$23,700.00View SEC Filing  
7/24/2015Jack W SingerEVPSell15,000$1.91$28,650.00View SEC Filing  
7/23/2015Louis A BiancoEVPSell10,000$1.91$19,100.00View SEC Filing  
7/6/2015Matthew PlunkettEVPSell10,000$1.95$19,500.00View SEC Filing  
6/26/2015Jack W SingerEVPSell15,000$2.07$31,050.00View SEC Filing  
6/25/2015Louis A BiancoEVPSell10,000$2.18$21,800.00View SEC Filing  
6/4/2015Matthew PlunkettEVPSell10,000$2.06$20,600.00View SEC Filing  
5/22/2015Jack W SingerEVPSell15,000$1.74$26,100.00View SEC Filing  
5/21/2015Louis A BiancoEVPSell10,000$1.80$18,000.00View SEC Filing  
5/4/2015Matthew PlunkettEVPSell10,000$1.86$18,600.00View SEC Filing  
4/24/2015Jack W SingerEVPSell15,000$1.96$29,400.00View SEC Filing  
4/23/2015Louis A BiancoEVPSell10,000$1.93$19,300.00View SEC Filing  
4/6/2015Matthew PlunkettEVPSell16,569$1.88$31,149.72View SEC Filing  
3/23/2015James A BiancoCEOSell175,199$1.95$341,638.05View SEC Filing  
3/23/2015Matthew PlunkettEVPSell59,130$1.96$115,894.80View SEC Filing  
3/20/2015Louis A BiancoEVPSell63,000$1.94$122,220.00View SEC Filing  
2/27/2015Jack W SingerEVPSell15,000$2.35$35,250.00View SEC Filing  
2/5/2015Louis A BiancoEVPSell10,000$2.22$22,200.00View SEC Filing  
2/4/2015Matthew PlunkettEVPSell12,000$2.22$26,640.00View SEC Filing  
1/8/2015Louis A BiancoEVPSell10,000$2.32$23,200.00View SEC Filing  
1/5/2015Matthew PlunkettEVPSell12,000$2.36$28,320.00View SEC Filing  
12/19/2014James A BiancoCEOSell40,000$2.44$97,600.00View SEC Filing  
12/4/2014Louis A BiancoEVPSell10,000$2.25$22,500.00View SEC Filing  
11/6/2014Louis A BiancoEVPSell10,000$2.37$23,700.00View SEC Filing  
10/6/2014Matthew PlunkettEVPSell12,000$2.39$28,680.00View SEC Filing  
9/23/2014Matthew PlunkettEVPSell103,635$2.56$265,305.60View SEC Filing  
9/22/2014James A BiancoCEOSell307,068$2.53$776,882.04View SEC Filing  
9/22/2014Matthew PlunkettEVPSell51,817$2.58$133,687.86View SEC Filing  
9/19/2014Louis A BiancoEVPSell145,000$2.59$375,550.00View SEC Filing  
9/4/2014Matthew PlunkettEVPSell27,301$2.48$67,706.48View SEC Filing  
8/15/2014James A BiancoCEOSell40,000$2.54$101,600.00View SEC Filing  
8/4/2014Matthew PlunkettEVPSell12,000$2.48$29,760.00View SEC Filing  
7/10/2014Louis A BiancoEVPSell10,000$2.73$27,300.00View SEC Filing  
7/7/2014Matthew PlunkettEVPSell12,000$2.89$34,680.00View SEC Filing  
6/27/2014James A BiancoCEOSell50,000$2.84$142,000.00View SEC Filing  
6/5/2014Louis A BiancoEVPSell10,000$2.97$29,700.00View SEC Filing  
5/1/2014Louis BiancoEVPSell10,000$2.91$29,100.00View SEC Filing  
3/28/2014Vartan GregorianDirectorSell82,000$3.41$279,620.00View SEC Filing  
3/25/2014Phillip Phd NudelmanDirectorSell100,000$3.56$356,000.00View SEC Filing  
3/24/2014Jack SingerEVPSell60,000$3.47$208,200.00View SEC Filing  
3/21/2014James BiancoCEOSell395,000$3.83$1,512,850.00View SEC Filing  
3/21/2014Matthew PlunkettEVPSell170,000$3.73$634,100.00View SEC Filing  
3/7/2014Fred TellingDirectorSell72,095$3.75$270,356.25View SEC Filing  
9/23/2013James A BiancoCEOSell130,551$1.50$195,826.50View SEC Filing  
8/30/2013James A BiancoCEOSell25,925$1.08$27,999.00View SEC Filing  
8/9/2013James A BiancoCEOSell40,000$1.07$42,800.00View SEC Filing  
8/7/2013Mary Oneil MundingerDirectorSell125,000$1.06$132,500.00View SEC Filing  
8/6/2013Phillip M Phd NudelmanDirectorSell50,000$1.09$54,500.00View SEC Filing  
7/26/2013James A BiancoCEOSell25,688$1.09$27,999.92View SEC Filing  
6/28/2013James A BiancoCEOSell26,053$1.08$28,137.24View SEC Filing  
6/5/2013Jack W SingerEVPSell10,000$1.26$12,600.00View SEC Filing  
5/31/2013James A BiancoCEOSell28,000$1.22$34,160.00View SEC Filing  
5/31/2013Louis A BiancoEVPSell33,712$1.24$41,802.88View SEC Filing  
5/30/2013Fred TellingDirectorSell64,798$1.24$80,349.52View SEC Filing  
5/24/2013Richard L LoveDirectorSell23,000$1.21$27,830.00View SEC Filing  
5/10/2013James A BiancoCEOSell25,000$1.16$29,000.00View SEC Filing  
5/9/2013Louis A BiancoEVPSell50,000$1.15$57,500.00View SEC Filing  
3/11/2013Jack W SingerEVPSell13,000$1.28$16,640.00View SEC Filing  
8/10/2012James A BiancoCEOSell10,000$0.42$4,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for CTI BioPharma Corp. (NASDAQ:CTIC)
DateHeadline
streetinsider.com logoCTI BioPharma (CTIC) Announces Pacritinib Phase 3 Met One co-Primary Endpoint; TSS Reduction Endpoint Missed (NASDAQ:CTIC)
www.streetinsider.com - August 29 at 4:39 PM
feeds.benzinga.com logoCTI BioPharma Meets One Of Two Endpoints In Phase 3 Trial (NASDAQ:CTIC)
feeds.benzinga.com - August 29 at 2:01 PM
rttnews.com logoCTI: Pacritinib End Trial For Advanced Myelofibrosis Met One Of Co-primary Goals (NASDAQ:CTIC)
www.rttnews.com - August 29 at 9:10 AM
finance.yahoo.com logoCTI BioPharma Announces Top-Line Results From PERSIST-2 Phase 3 Trial Of Pacritinib For High-Risk Patients With Advanced Myelofibrosis (NASDAQ:CTIC)
finance.yahoo.com - August 29 at 9:10 AM
News IconCTI BioPharma Corp (NASDAQ:CTIC) Analyst Opinion - The Independent Republic (NASDAQ:CTIC)
theindependentrepublic.com - August 24 at 4:26 PM
News IconTime To Put On The Watch List? - CTI BioPharma Corp. (NASDAQ:CTIC), Spark Therapeutics, Inc. (NASDAQ:ONCE) - The Voice Registrar (NASDAQ:CTIC)
voiceregistrar.com - August 18 at 9:41 PM
finance.yahoo.com logoCTI BIOPHARMA CORP Financials (NASDAQ:CTIC)
finance.yahoo.com - August 13 at 4:27 PM
publicnow.com logoBrainStorm Cell Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:CTIC)
www.publicnow.com - August 11 at 9:41 AM
equities.com logoCTI BioPharma Corp. (CTIC) Jumps 7.24% on August 03 | Equities ... - Equities.com (NASDAQ:CTIC)
www.equities.com - August 5 at 10:40 AM
rttnews.com logoEARNINGS SUMMARY: Details of CTI BioPharma Corp. Q2 Earnings Report (NASDAQ:CTIC)
www.rttnews.com - August 4 at 10:10 PM
sg.finance.yahoo.com logoCTI BioPharma reports 2Q loss (NASDAQ:CTIC)
sg.finance.yahoo.com - August 4 at 10:09 PM
finance.yahoo.com logoCTI BioPharma Reports Second Quarter 2016 Financial Results (NASDAQ:CTIC)
finance.yahoo.com - August 4 at 4:41 PM
fortune.com logoThe Insider Activity Don't Lie: CTI BioPharma Corp. (NASDAQ:CTIC ... - Review Fortune (NASDAQ:CTIC)
reviewfortune.com - August 2 at 4:35 PM
streetupdates.com logoAnalysts Ranking Activities: Sophiris Bio, Inc. (NASDAQ:SPHS) , CTI BioPharma Corp. (NASDAQ:CTIC) - Street Updates (NASDAQ:CTIC)
www.streetupdates.com - August 2 at 9:16 AM
streetupdates.com logoKeep an eye on Analyst Actions: CTI BioPharma Corp. (NASDAQ:CTIC) , Novo Nordisk A/S (NYSE:NVO) - Street Updates (NASDAQ:CTIC)
www.streetupdates.com - July 27 at 10:10 PM
equities.com logoCTI BioPharma Corp. (CTIC) Drops 9.12% on July 26 | Equities.com - Equities.com (NASDAQ:CTIC)
www.equities.com - July 27 at 10:10 PM
News IconShares Stumbling of Late: CTI BioPharma Corp. (NASDAQ:CTIC) - TGP (NASDAQ:CTIC)
telanaganapress.com - July 23 at 8:08 AM
News IconStreet Analyst EPS Growth Watch in Review CTI BioPharma Corp. (NASDAQ:CTIC) - TGP (NASDAQ:CTIC)
telanaganapress.com - July 22 at 3:52 PM
News IconConcentrating on Shares of CTI BioPharma Corp. (NASDAQ:CTIC) - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - July 21 at 4:36 PM
News IconMarket Minute - Focus on CTI BioPharma Corp. (NASDAQ:CTIC) Stock - TGP (NASDAQ:CTIC)
telanaganapress.com - July 21 at 4:36 PM
capitalcube.com logoETF’s with exposure to CTI BioPharma Corp. : July 20, 2016 (NASDAQ:CTIC)
www.capitalcube.com - July 20 at 12:18 PM
News IconSession Focus - Highlighting Shares of: CTI BioPharma Corp. (NASDAQ:CTIC) - TGP (NASDAQ:CTIC)
telanaganapress.com - July 19 at 4:32 PM
feeds.reuters.com logoUPDATE 1-Brainstorm's cell therapy succeeds in ALS mid-stage study (NASDAQ:CTIC)
feeds.reuters.com - July 18 at 9:49 AM
News IconCTI BioPharma Corp. (NASDAQ:CTIC) Earnings Review and Target Watch - TGP (NASDAQ:CTIC)
telanaganapress.com - July 17 at 4:13 PM
News IconEPS Growth Watch for CTI BioPharma Corp. (NASDAQ:CTIC) - TGP (NASDAQ:CTIC)
telanaganapress.com - July 17 at 4:13 PM
News IconTrading Focus on Shares of: CTI BioPharma Corp. (NASDAQ:CTIC) - TGP (NASDAQ:CTIC)
telanaganapress.com - July 17 at 4:13 PM
News IconCompany Sentiment Score Update:CTI BioPharma Corp. (NASDAQ:CTIC) - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - July 13 at 11:13 AM
News IconFocus Stock Trading Recap : CTI BioPharma Corp. (NASDAQ:CTIC) - Telanagana Press (NASDAQ:CTIC)
telanaganapress.com - July 10 at 4:18 PM
News IconCompany Share Performance in Review: CTI BioPharma Corp. (NASDAQ:CTIC) - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - July 10 at 4:18 PM
News IconPrice Target Review and Earnings Check on CTI BioPharma Corp. (NASDAQ:CTIC) - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - July 10 at 4:18 PM
News IconCTI BioPharma Corp. (NASDAQ:CTIC): Check on Company Stock Performance - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - July 10 at 4:18 PM
News IconActive Stock Tracker: CTI BioPharma Corp. (NASDAQ:CTIC) - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - July 8 at 9:31 PM
equities.com logoCTI BioPharma Corp. (CTIC) Jumps 6.91% on July 07 - Equities.com (NASDAQ:CTIC)
www.equities.com - July 7 at 9:41 PM
News IconEarnings Review and Price Target Watch for CTI BioPharma Corp. (NASDAQ:CTIC) - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - July 7 at 4:29 PM
news.cmlviz.com logoCTI BioPharma Corp. (NasdaqCM:CTIC) Fundamental Star Rating Report - CML News (NASDAQ:CTIC)
news.cmlviz.com - July 7 at 4:29 PM
News IconHC Stocks in the Rumor: Bristol-Myers Squibb Co (NYSE:BMY), CTI BioPharma Corp (NASDAQ:CTIC) - share market updates (press release) (NASDAQ:CTIC)
sharemarketupdates.com - July 6 at 4:32 PM
News IconActive Stock Update on Shares of : CTI BioPharma Corp. (NASDAQ:CTIC) - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - July 6 at 4:32 PM
News IconWhich Way is Stock Sentiment Leaning on :CTI BioPharma Corp. (NASDAQ:CTIC) - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - July 6 at 4:32 PM
equities.com logoCTI BioPharma Corp. (CTIC) Jumps 5.41% on July 04 - Equities.com (NASDAQ:CTIC)
www.equities.com - July 6 at 4:32 PM
News IconShare Performance Recap for: CTI BioPharma Corp. (NASDAQ:CTIC) - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - July 4 at 4:16 PM
News IconStock Sentiment Watch for:CTI BioPharma Corp. (NASDAQ:CTIC) - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - July 4 at 4:16 PM
News IconCheck on Earnings and Price Target CTI BioPharma Corp. (NASDAQ:CTIC) - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - July 2 at 4:29 PM
equities.com logoCTI BioPharma Corp. (CTIC) Drops 6.87% on June 30 - Equities.com (NASDAQ:CTIC)
www.equities.com - July 2 at 10:11 AM
biz.yahoo.com logoResults of Operations and Financial Condition, Regulation FD Disclosure, Finan (NASDAQ:CTIC)
biz.yahoo.com - June 30 at 9:48 PM
biz.yahoo.com logoCTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Finan (NASDAQ:CTIC)
biz.yahoo.com - June 30 at 4:47 PM
equities.com logoCTI BioPharma Corp. (CTIC) Jumps 14.39% on June 28 - Equities.com (NASDAQ:CTIC)
www.equities.com - June 29 at 10:41 AM
News IconFocus Stock Recap for: CTI BioPharma Corp. (NASDAQ:CTIC) - Telanagana Press (NASDAQ:CTIC)
telanaganapress.com - June 28 at 4:25 PM
wallstrt24.com logoEMC Corporation (NYSE:EMC) & CTI BioPharma (NASDAQ:CTIC) Stocks in the Spotlight - Wall Street 24 (NASDAQ:CTIC)
wallstrt24.com - June 28 at 4:25 PM
News IconCTI BioPharma Corp. (NASDAQ:CTIC): Reviewing Stock Performance - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - June 28 at 4:25 PM
News IconTarget Price Consensus Focus on CTI BioPharma Corp. (NASDAQ:CTIC) - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - June 28 at 4:25 PM

Social

CTI BioPharma Corp. (NASDAQ:CTIC) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff